- Selection of P2Y12 antagonist, treatment initiation, and predictors of high on-treatment platelet reactivity in a "Real World" registry2015 | Third Faculty of Medicine
- Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative2020 | First Faculty of Medicine
- Initial antibiotic treatment of serious bacterial infections2019 | Third Faculty of Medicine
- Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS2019 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Recommended procedure for the initiation of treatment of Parkinson's disease2009 | First Faculty of Medicine
- Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis2021 | First Faculty of Medicine
- Urgent urinary incontinencePublication without faculty affiliation
- Beta blockers in the treatment of acute heart failure2010 | First Faculty of Medicine
- Multiple sclerosis: treatment safety2018 | Faculty of Medicine in Hradec Králové
- Multiple sclerosis: adherence to treatment2020 | Faculty of Medicine in Hradec Králové
- Autologous Hematopoietic Stem Cells Transplantation and its Current Role in Multiple Sclerosis Treatment2009 | First Faculty of Medicine, Third Faculty of Medicine
- Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial2014 | First Faculty of Medicine
- Multiple sclerosis: treatment, monitoring, activity and disability2018 | Faculty of Medicine in Hradec Králové
- Parameter NEDA-3 from the point of view of current treatment of multiple sclerosis2023 | Faculty of Medicine in Hradec Králové
- Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry2014 | First Faculty of Medicine
- Interferon Beta Therapy in a Patient with Clinically Isolated Syndrome - a Case Report2013 | First Faculty of Medicine
- Hyponatremia2015 | First Faculty of Medicine
- Systemic lupus erythematosus and diabetes mellitus2005 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Interferon beta in the current treatment of multiple sclerosis2013 | First Faculty of Medicine
- Is surgical treatment of liver metastases from pancreatic adenocarcinoma currently indicated?2023 | Third Faculty of Medicine
- Treatment of dyslipidemia in the elderly: understanding cardiovascular risk tables and when to start treatment2023 | Faculty of Medicine in Hradec Králové
- Antipsychotic Drug Treatment in First-Episode Psychosis. Should Patients be Switched to a Different Antipsychotic Drug After 2, 4, or 6 Weeks of Nonresponse?2010 | Faculty of Medicine in Hradec Králové
- Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients2017 | First Faculty of Medicine
- Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV InfectionPublication without faculty affiliation
- Immobilization of Chitosan Onto Polypropylene Foil via Air/Solution Atmospheric Pressure Plasma Afterglow Treatment2020 | Faculty of Mathematics and Physics
- Long‑term effect of siponimod on MRI outcomes in patients with secondary‑progressive multiple sclerosis2022 | Faculty of Medicine in Hradec Králové
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Symptomatic treatment of neurologic symptoms in Wilson disease2017 | First Faculty of Medicine